Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer

被引：134
|
作者：
Mohibi, Shakur
Chen, Xinbin
Zhang, Jin
机构：
[1] Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, Comparat Oncol Lab, Davis, CA 95616 USA
来源：
PHARMACOLOGY & THERAPEUTICS | 2019年 / 203卷
关键词：
RNA-binding proteins; RNA-binding domains; Cancer therapeutics; Small molecules; siRNA; Peptide; Aptamer; TRANSLATION INITIATION-FACTOR; CAP-DEPENDENT TRANSLATION; DEAD-BOX PROTEIN; AU-RICH ELEMENT; TUMOR-SUPPRESSOR GENE; NUCLEAR RIBONUCLEOPROTEIN K; SMALL-MOLECULE INHIBITION; P21; MESSENGER-RNA; EPITHELIAL-MESENCHYMAL TRANSITION; MYELOID CELL-PROLIFERATION;
D O I：
10.1016/j.pharmthera.2019.07.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
RNA-binding proteins (RBPs) play a critical role in the regulation of various RNA processes, including splicing, cleavage and polyadenylation, transport, translation and degradation of coding RNAs, non-coding RNAs and microRNAs. Recent studies indicate that RBPs not only play an instrumental role in normal cellular processes but have also emerged as major players in the development and spread of cancer. Herein, we review the current knowledge about RNA binding proteins and their role in tumorigenesis as well as the potential to target RBPs for cancer therapeutics. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页数：25
相关论文
共 50 条
  • [1] RNA-binding proteins as therapeutic targets in cancer
    Jungfleisch, Jennifer
    Gebauer, Fatima
    RNA BIOLOGY, 2025, 22 (01) : 1 - 8
  • [2] RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer
    Singh, Vikash
    Singh, Amandeep
    Liu, Alvin John
    Fuchs, Serge Y.
    Sharma, Arun K.
    Spiegelman, Vladimir S.
    CANCERS, 2024, 16 (20)
  • [3] Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets
    Kudinov, Alexander E.
    Karanicolas, John
    Golemis, Erica A.
    Boumber, Yanis
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2143 - 2153
  • [4] Alternative splicing perturbation landscape identifies RNA binding proteins as potential therapeutic targets in cancer
    Li, Junyi
    Pan, Tao
    Chen, Liuxin
    Wang, Qi
    Chang, Zhenghong
    Zhou, Weiwei
    Li, Xinhui
    Xu, Gang
    Li, Xia
    Li, Yongsheng
    Zhang, Yunpeng
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 24 : 792 - 806
  • [5] RNA-Binding Proteins in Cancer: Functional and Therapeutic Perspectives
    Kang, Donghee
    Lee, Yerim
    Lee, Jae-Seon
    CANCERS, 2020, 12 (09) : 1 - 33
  • [6] CARD proteins as therapeutic targets in cancer
    Damiano, JS
    Reed, JC
    CURRENT DRUG TARGETS, 2004, 5 (04) : 367 - 374
  • [7] Salinomycin and its Binding Proteins as Novel Rational Therapeutic Targets in Pancreatic Cancer
    Qi, D.
    Zhou, S.
    Wang, F.
    Wong, L.
    Huang, J. H.
    Wu, E.
    PANCREAS, 2019, 48 (10) : 1510 - 1510
  • [8] BET Bromodomain Proteins as Cancer Therapeutic Targets
    Shu, Shaokun
    Polyak, Kornelia
    TARGETING CANCER, VOL 81, 2016, 2016, 81 : 123 - 129
  • [9] microRNAs, RNA binding proteins and cancer
    Agami, Reuven
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (04) : 370 - 374
  • [10] The inhibitor of apoptosis proteins as therapeutic targets in cancer
    Vucic, Domagoj
    Fairbrother, Wayne J.
    CLINICAL CANCER RESEARCH, 2007, 13 (20) : 5995 - 6000
12345